NVS

NOVARTIS AG

NVS·66987V109·US·ADR·Healthcare - Drug Manufacturers - General-13D/G

NVS institutional ownership changes in Q2 2026: 112 institutions opened or added positions, 114 trimmed or exited. NVS (NOVARTIS AG) is held by 220 institutional investors as of Q2 2026. Top institutional shareholders: Fisher Asset Management, LLC ($2.4B), MORGAN STANLEY ($1.4B), DIMENSIONAL FUND ADVISORS LP ($1.3B). Net institutional sentiment: Mixed.

220
Holders
(34 Elite)
$17.8B
Total Value
50% (226)
Consensus
112 buying - 114 selling
13F: Insider & Congress: Updated regularly
NVS

Smart Money Verdict

View all
Loading verdict
Held by 220 funds
34 elite

Who's Trading

Source dates: Price Oct 23, 2026 · Insiders none · Activists Jul 17, 2025 · Congress Sep 25, 2026

CongressKevin HernKevin HernSale $15,001 - $50,000Aug 27, 2026
CongressAAAlan ArmstrongBuy $1,001 - $15,000Mar 31, 2026
CongressAAAlan ArmstrongBuy $15,001 - $50,000Mar 30, 2026
Checking access…

Top Holders

Checking access…
Action
Increased
15.5M(+11.8%)$2.4B0.7%+16.82%
50
Increased
8.7M(+2.3%)$1.4B0.1%+40.94%
33
Increased
8.1M(+0.1%)$1.3B0.2%+82.71%
38
Decreased
6.6M(-12.9%)$1B0.6%+156.86%
0
Decreased
5.2M(-3.4%)$821.1M1.0%+114.62%
0
Decreased
4.9M(-1.1%)$769.5M0.0%+71.34%
0
Decreased
3.3M(-4.7%)$509.5M0.1%+89.22%
0
Increased
3M(+3.3%)$477.7M0.0%+30.65%
32
Decreased
3M(-54.3%)$467.1M0.0%+16.20%
0
Increased
2.8M(+0.2%)$437.7M0.1%+70.42%
31
Increased
2.3M(+0.8%)$365.3M0.1%+45.26%
31
Increased
2.3M(+25.5%)$356.9M0.0%+5.82%
38
First report
2.2M$348.1M0.1%-3.89%
0
Decreased
2.2M(-12.1%)$337.1M0.6%+18.65%
0
Increased
2.1M(+21.5%)$322.4M0.0%+53.75%
37
Decreased
2M(-0.2%)$318.6M3.1%+85.43%
0
Increased
2M(+8.4%)$306.8M0.1%+2.11%
40
Increased
1.9M(+30.1%)$300.1M0.5%-1.98%
55
Decreased
1.8M(-3.5%)$286.6M0.0%+111.85%
0
Decreased
1.8M(-6.8%)$282.3M0.1%+35.62%
0

Showing 1-20 of 233

1 / 12
NVSNVSNOVARTIS AG

Other Healthcare stocks held by institutions

Data sourced from four public-disclosure sources: SEC 13F, Form 4, 13D/13G, and House/Senate STOCK Act disclosures. Not financial advice. Full disclaimer

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used